In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...

BHUBANESWAR: In a major push to accelerate bio-industrialisation, the state government has announced a comprehensive ...

As of Friday, January 09, Zhengye Biotechnology Holding Limited’s ZYBT share price has surged by 5.27%, which has investors ...

Thinking about age as a modifiable risk factor is reshaping how veterinarians approach care for aging dogs.

One of the ones that we're particularly interested in at Loyal is something called metabolic dysfunction. As people and dogs ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...

Access the Akari CEO Corner hereTAMPA, Fla. and LONDON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: ...

SEED Therapeutics, Inc. ("SEED"), a clinical-stage biotechnology company specializing in molecular glue degraders, today announced the dosing of the first patient in its Phase 1a dose-escalation study ...

A new type of “smart pill” designed to confirm when medications are actually swallowed could one day help doctors better ...

Danish biotech startup Bactolife has secured more than €30 million in a Series B funding round, marking a significant ...

Xellar Biosystems ("Xellar"), a globally leading innovator in next-generation artificial intelligence- and computer vision–assisted, organ-on-a-chip–based drug discovery and development platforms, ...

Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that the ...